Archives of Neuroscience

Published by: Kowsar

Association of Interleukin-12B Gene Polymorphism With Multiple Sclerosis in Patients From Southeast of Iran

Maryam Nemati 1 , Hossain-Ali Ebrahimi 2 , Hossain Hajghani 3 , Arezoo Khosravimashizi 3 and Abdollah Jafarzadeh 3 , 4 , *
Authors Information
1 Department of Laboratory Sciences, Paramedical School, Kerman University of Medical Sciences, Kerman, IR Iran
2 Neurology Research Center, Department of Neurology, Kerman University of Medical Sciences, Kerman, IR Iran
3 Department of Immunology, Medical School, Kerman University of Medical Sciences, Kerman, IR Iran
4 Molecular Medicine Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, IR Iran
Article information
  • Archives of Neuroscience: April 2018, 5 (2); e63360
  • Published Online: April 14, 2018
  • Article Type: Research Article
  • Received: October 28, 2017
  • Accepted: January 6, 2018
  • DOI: 10.5812/archneurosci.63360

To Cite: Nemati M, Ebrahimi H, Hajghani H, Khosravimashizi A, Jafarzadeh A. Association of Interleukin-12B Gene Polymorphism With Multiple Sclerosis in Patients From Southeast of Iran, Arch Neurosci. 2018 ; 5(2):e63360. doi: 10.5812/archneurosci.63360.

Copyright © 2018, Archives of Neuroscience. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Methods
3. Results
4. Discussion
  • 1. Confavreux C, Vukusic S. The clinical course of multiple sclerosis. Handb Clin Neurol. 2014;122:343-69. doi: 10.1016/B978-0-444-52001-2.00014-5. [PubMed: 24507525].
  • 2. Ghaffari SA, Nemati M, Hajghani H, Ebrahimi H, Sheikhi A, Jafarzadeh A. Circulating concentrations of interleukin (IL)-17 in patients with multiple sclerosis: Evaluation of the effects of gender, treatment, disease patterns and IL-23 receptor gene polymorphisms. Iran J Neurol. 2017;16(1):15-25. [PubMed: 28717429]. [PubMed Central: PMC5506751].
  • 3. Jafarzadeh A, Azizi SV, Nemati M, Khoramdel-Azad H, Shamsizadeh A, Ayoobi F, et al. Ginger Extract Reduces the Expression of IL-17 and IL-23 in the Sera and Central Nervous System of EAE Mice. Iran J Immunol. 2015;12(4):288-301. [PubMed: 26714420].
  • 4. Etesam Z, Nemati M, Ebrahimizadeh MA, Ebrahimi HA, Hajghani H, Khalili T, et al. Altered Expression of Specific Transcription Factors of Th17 (RORgammat, RORalpha) and Treg Lymphocytes (FOXP3) by Peripheral Blood Mononuclear Cells from Patients with Multiple Sclerosis. J Mol Neurosci. 2016;60(1):94-101. doi: 10.1007/s12031-016-0789-5. [PubMed: 27370539].
  • 5. Jafarzadeh A, Jamali M, Mahdavi R, Ebrahimi HA, Hajghani H, Khosravimashizi A, et al. Circulating levels of interleukin-35 in patients with multiple sclerosis: evaluation of the influences of FOXP3 gene polymorphism and treatment program. J Mol Neurosci. 2015;55(4):891-7. doi: 10.1007/s12031-014-0443-z. [PubMed: 25326790].
  • 6. Jafarzadeh A, Mahdavi R, Jamali M, Hajghani H, Nemati M, Ebrahimi HA. Increased Concentrations of Interleukin-33 in the Serum and Cerebrospinal Fluid of Patients with Multiple Sclerosis. Oman Med J. 2016;31(1):40-5. doi: 10.5001/omj.2016.08. [PubMed: 26813806]. [PubMed Central: PMC4720939].
  • 7. Jafarzadeh A, Ebrahimi HA, Bagherzadeh S, Zarkesh F, Iranmanesh F, Najafzadeh A, et al. Lower serum levels of Th2-related chemokine CCL22 in women patients with multiple sclerosis: a comparison between patients and healthy women. Inflammation. 2014;37(2):604-10. doi: 10.1007/s10753-013-9775-z. [PubMed: 24254331].
  • 8. Jafarzadeh A, Bagherzadeh S, Ebrahimi HA, Hajghani H, Bazrafshani MR, Khosravimashizi A, et al. Higher circulating levels of chemokine CCL20 in patients with multiple sclerosis: evaluation of the influences of chemokine gene polymorphism, gender, treatment and disease pattern. J Mol Neurosci. 2014;53(3):500-5. doi: 10.1007/s12031-013-0214-2. [PubMed: 24395091].
  • 9. Kroenke MA, Carlson TJ, Andjelkovic AV, Segal BM. IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J Exp Med. 2008;205(7):1535-41. doi: 10.1084/jem.20080159. [PubMed: 18573909]. [PubMed Central: PMC2442630].
  • 10. Fletcher JM, Lalor SJ, Sweeney CM, Tubridy N, Mills KH. T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Exp Immunol. 2010;162(1):1-11. doi: 10.1111/j.1365-2249.2010.04143.x. [PubMed: 20682002]. [PubMed Central: PMC2990924].
  • 11. Jafarzadeh A, Ahangar-Parvin R, Nemat M, Taghipour Z, Shamsizadeh A, Ayoobi F, et al. Ginger extract modulates the expression of IL-12 and TGF-beta in the central nervous system and serum of mice with experimental autoimmune encephalomyelitis. Avicenna J Phytomed. 2017;7(1):54-65. [PubMed: 28265547]. [PubMed Central: PMC5329177].
  • 12. Lasek W, Zagozdzon R, Jakobisiak M. Interleukin 12: still a promising candidate for tumor immunotherapy? Cancer Immunol Immunother. 2014;63(5):419-35. [PubMed: 24514955]. [PubMed Central: PMC3994286].
  • 13. Xiao BG, Ma CG, Xu LY, Link H, Lu CZ. IL-12/IFN-gamma/NO axis plays critical role in development of Th1-mediated experimental autoimmune encephalomyelitis. Mol Immunol. 2008;45(4):1191-6. doi: 10.1016/j.molimm.2007.07.003. [PubMed: 17697713].
  • 14. Jana M, Mondal S, Jana A, Pahan K. Interleukin-12 (IL-12), but not IL-23, induces the expression of IL-7 in microglia and macrophages: implications for multiple sclerosis. Immunology. 2014;141(4):549-63. doi: 10.1111/imm.12214. [PubMed: 24224652]. [PubMed Central: PMC3956429].
  • 15. Lee LF, Axtell R, Tu GH, Logronio K, Dilley J, Yu J, et al. IL-7 promotes T(H)1 development and serum IL-7 predicts clinical response to interferon-beta in multiple sclerosis. Sci Transl Med. 2011;3(93):93ra68. doi: 10.1126/scitranslmed.3002400. [PubMed: 21795588]. [PubMed Central: PMC3739690].
  • 16. Croxford AL, Kulig P, Becher B. IL-12-and IL-23 in health and disease. Cytokine Growth Factor Rev. 2014;25(4):415-21. doi: 10.1016/j.cytogfr.2014.07.017. [PubMed: 25130295].
  • 17. Zhou L, Yao F, Luan H, Wang Y, Dong X, Zhou W, et al. Functional polymorphisms in the interleukin-12 gene contribute to cancer risk: evidence from a meta-analysis of 18 case-control studies. Gene. 2012;510(1):71-7. doi: 10.1016/j.gene.2012.08.019. [PubMed: 22940148].
  • 18. Tahmasebi Z, Akbarian M, Mirkazemi S, Shahlaee A, Alizadeh Z, Amirzargar AA, et al. Interleukin-1 gene cluster and IL-1 receptor polymorphisms in Iranian patients with systemic lupus erythematosus. Rheumatol Int. 2013;33(10):2591-6. doi: 10.1007/s00296-013-2784-2. [PubMed: 23722873].
  • 19. Peresi E, Oliveira LR, da Silva WL, da Costa EA, Araujo JJ, Ayres JA, et al. Cytokine Polymorphisms, Their Influence and Levels in Brazilian Patients with Pulmonary Tuberculosis during Antituberculosis Treatment. Tuberc Res Treat. 2013;2013:285094. doi: 10.1155/2013/285094. [PubMed: 23634300]. [PubMed Central: PMC3619634].
  • 20. Selvaraj P, Alagarasu K, Harishankar M, Vidyarani M, Nisha Rajeswari D, Narayanan PR. Cytokine gene polymorphisms and cytokine levels in pulmonary tuberculosis. Cytokine. 2008;43(1):26-33. doi: 10.1016/j.cyto.2008.04.011. [PubMed: 18522869].
  • 21. Chen T, Liang W, Gao L, Wang Y, Liu Y, Zhang L, et al. Association of single nucleotide polymorphisms in interleukin 12 (IL-12A and -B) with asthma in a Chinese population. Hum Immunol. 2011;72(7):603-6. doi: 10.1016/j.humimm.2011.03.018. [PubMed: 21513752].
  • 22. Wang EY, Yang Q, Liao ZG. Association of polymorphisms in interleukin (IL)-12A and -B genes with rheumatoid arthritis in a Chinese population. Clin Exp Immunol. 2015;180(1):83-9. doi: 10.1111/cei.12563. [PubMed: 25469793]. [PubMed Central: PMC4367096].
  • 23. Lopez-Hernandez R, Valdes M, Campillo JA, Martinez-Garcia P, Salama H, Bolarin JM, et al. Pro- and anti-inflammatory cytokine gene single-nucleotide polymorphisms in inflammatory bowel disease. Int J Immunogenet. 2015;42(1):38-45. [PubMed: 25359546].
  • 24. Li XL, Wu CF, Wu GS. Genetic variations of cytokines and cytokine receptors in psoriasis patients from china. Int J Genomics. 2014;2014:870597.
  • 25. Wong RH, Wei JC, Huang CH, Lee HS, Chiou SY, Lin SH, et al. Association of IL-12B genetic polymorphism with the susceptibility and disease severity of ankylosing spondylitis. J Rheumatol. 2012;39(1):135-40. doi: 10.3899/jrheum.110613. [PubMed: 22045842].
  • 26. Eiris N, Gonzalez-Lara L, Santos-Juanes J, Queiro R, Coto E, Coto-Segura P. Genetic variation at IL12B, IL23R and IL23A is associated with psoriasis severity, psoriatic arthritis and type 2 diabetes mellitus. J Dermatol Sci. 2014;75(3):167-72. doi: 10.1016/j.jdermsci.2014.05.010. [PubMed: 24957500].
  • 27. Liu M, Hu X, Wang Y, Chen X, Wu J. Association of IL-23 and its receptor gene single-nucleotide polymorphisms with multiple sclerosis in Chinese southern population. Int J Neurosci. 2014;124(12):904-7. doi: 10.3109/00207454.2014.894044. [PubMed: 24547735].
  • 28. Alifirova VM, Orlova I, Babenko SA, Rudko AA, Puzyrev VP. [The 1188 A/C ILI2B gene polymorphism in patients with multiple sclerosis and in healthy subjects of Tomsk region]. Vserossiiskoe Obshchestvo Psikhiat. 2006;3:130-5.
  • 29. Hall MA, McGlinn E, Coakley G, Fisher SA, Boki K, Middleton D, et al. Genetic polymorphism of IL-12 p40 gene in immune-mediated disease. Genes Immun. 2000;1(3):219-24. doi: 10.1038/sj.gene.6363661. [PubMed: 11196715].
  • 30. Huang J, Yang Y, Zhou F, Liang Z, Kang M, Kuang Y, et al. Meta-analysis of the IL23R and IL12B polymorphisms in multiple sclerosis. Int J Neurosci. 2016;126(3):205-12. doi: 10.3109/00207454.2015.1007508. [PubMed: 26000455].
  • 31. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292-302. doi: 10.1002/ana.22366. [PubMed: 21387374]. [PubMed Central: PMC3084507].
  • 32. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215. [PubMed: 3344216]. [PubMed Central: PMC334765].
  • 33. Li X, Bai L, Fang J, Hou S, Zhou Q, Yu H, et al. Genetic variations of IL-12B, IL-12Rbeta1, IL-12Rbeta2 in Behcet's disease and VKH syndrome. PLoS One. 2014;9(5). e98373. doi: 10.1371/journal.pone.0098373. [PubMed: 24859272]. [PubMed Central: PMC4032269].
  • 34. Stanilova S, Miteva L. Taq-I polymorphism in 3'UTR of the IL-12B and association with IL-12p40 production from human PBMC. Genes Immun. 2005;6(4):364-6. doi: 10.1038/sj.gene.6364213. [PubMed: 15858599].
  • 35. Wang J, Nong L, Wei Y, Qin S, Zhou Y, Tang Y. Association of interleukin-12 polymorphisms and serum IL-12p40 levels with osteosarcoma risk. DNA Cell Biol. 2013;32(10):605-10. doi: 10.1089/dna.2013.2098. [PubMed: 23991654].
  • 36. Ong'echa JM, Raballah EO, Kempaiah PM, Anyona SB, Were T, Davenport GC, et al. Polymorphic variability in the 3' untranslated region (UTR) of IL12B is associated with susceptibility to severe anaemia in Kenyan children with acute Plasmodium falciparum malaria. BMC Genet. 2011;12:69. doi: 10.1186/1471-2156-12-69. [PubMed: 21819616]. [PubMed Central: PMC3166270].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments